Drug Overdose Deaths Rose More Among Black and Indigenous Americans During COVID-19 Pandemic
As COVID-19 consumed the U.S. in 2020, another health crisis was also raging: the drug overdose epidemic. Nearly 92,000 people died from drug overdoses that year, a 30% increase from 2019.
While overdose deaths rose across the population, the increase in deaths was far steeper among Black, American Indian, and Alaska Native people, according to data published July 19 in the U.S. Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report. Overdose deaths rose 44% among Black people from 2019 to 2020, and 39% among American Indian and Alaska Native persons, according to the CDC’s ana...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Drugs healthscienceclimate Source Type: news
FREE CONTACT HOUR: JHSON Virtual Nursing Grand Rounds
p{
margin:10px 0;
padding:0;
}
table{
border-collapse:collapse;
}
h1,h2,h3,h4,h5,h6{
display:block;
margin:0;
padding:0;
}
img,a img{
border:0;
height:auto;
outline:none;
text-decoration:none;
}
body,#bodyTable,#bodyCell{
height:100%;
margin:0;
padding:0;
width:100%;
}
.mcnPreviewText{
display:none !important;
}
#outlook a{
padding:0;
}
img{
-ms-interpolation-mode:bicubic;
}
table{
mso-table-lspace:0pt;
mso-table-rspace:0pt;
}
.ReadMsgBody{
width:100%;
}
.ExternalClass{
width:100%;
}
p,a,li,td,blockquote{
...
Source: Johns Hopkins University and Health Systems Archive - July 13, 2022 Category: Nursing Source Type: news
Suvorexant May Ease Symptoms During Opioid Withdrawal Therapy
Small pilot study suggests suvorexant may improve sleep, reduce opioid withdrawal and craving during buprenorphine/naloxone taper (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 12, 2022 Category: Psychiatry Tags: Pharmacy, Psychiatry, Journal, Source Type: news
Suvorexant May Ease Symptoms During Opioid Withdrawal Therapy
TUESDAY, July 12, 2022 -- For individuals with opioid use disorder undergoing a buprenorphine/naloxone taper, suvorexant might be a promising treatment for reducing sleep disturbance and easing opioid withdrawal, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 12, 2022 Category: Pharmaceuticals Source Type: news
Fewer Than Half of U.S. Pharmacies Carry One of the Most Effective Drugs for Opioid Abuse
Today’s illicit drug supply is riskier than ever, experts say. It’s often contaminated by different dangerous substances—from the potent opioid fentanyl, to the horse tranquilizer xylazine, to benzodiazepines—which makes using illegal drugs more unpredictable and raises the risk of overdose.
These risks make effective treatments indispensable. However, one of the most successful treatments for opioid dependence—buprenorphine—is difficult to get at most pharmacies across the country, according to a new study published in the journal Drug and Alcohol Dependence.
Researchers conducted secre...
Source: TIME: Health - June 10, 2022 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized Addiction healthscienceclimate Source Type: news
Former Malden Firefighter Charged with Possession and Distribution of Controlled Substances
FDA OCI, Joshua Eisnor, North Reading MA, charge, indictment, guilty plea, distribute, controlled substance, oxycodone, suboxone, Klonopin, Adderall, firefighter, Malden Fire Department, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - June 2, 2022 Category: Medical Law Authors: DOJ Source Type: news
Co-occurring depression and suicidal ideation in opioid use disorder: prevalence and response during treatment with buprenorphine-naloxone and injection naltrexone - Na PJ, Scodes J, Fishman M, Rotrosen J, Nunes EV.
OBJECTIVE: The concept of "deaths of despair" (suicide, overdose, and alcohol-related liver disease) highlights the importance of detecting and understanding the course of co-occurring depression in patients with opioid use disorder (OUD). METHODS:... (Source: SafetyLit)
Source: SafetyLit - April 25, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Facilitators of and barriers to buprenorphine initiation for people with opioid use disorder in the emergency department: protocol for a scoping review - Bozinoff N, Soobiah C, Rodak T, Bucago C, Kingston K, Klaiman M, Poynter B, Samuels G, Schoenfeld E, Shelton D, Kalocsai C.
INTRODUCTION: Buprenorphine-naloxone is recommended as a first-line agent for the treatment of opioid use disorder. Although initiation of buprenorphine in the emergency department (ED) is evidence based, barriers to implementation persist. A comprehensive... (Source: SafetyLit)
Source: SafetyLit - September 30, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Rethinking What it Means to Recover from Addiction
When I kicked cocaine and heroin in 1988, I was told that there was only one way to get better: abstain forever from psychoactive substances including alcohol—and practice the 12 steps made famous by Alcoholics Anonymous. The only alternative, counselors and group members said, was “jails, institutions or death.”
My addiction was so extreme that by the end, I was injecting dozens of times a day. So I grabbed the lifeline I was thrown and attended the traditional 12-step rehab program recommended by the hospital where I underwent withdrawal.
But once I began to study the scientific data on addiction, I lea...
Source: TIME: Health - September 29, 2021 Category: Consumer Health News Authors: Maia Szalavitz Tags: Uncategorized Source Type: news
Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: results from a multisite trial of buprenorphine-naloxone and methadone - Zhu Y, Mooney LJ, Yoo C, Evans EA, Kelleghan A, Saxon AJ, Curtis ME, Hser YI.
We examined long-term treatment experiences and outcomes by type of psychiatric disorder among participants w... (Source: SafetyLit)
Source: SafetyLit - September 27, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Buprenorphine/naloxone associated with a reduced odds of fentanyl exposure among a cohort of people who use drugs in Vancouver, Canada - Young S, Hayashi K, Grant C, Milloy MJ, Debeck K, Wood E, Fairbairn N.
This study aimed to estimate the association between current use of different forms of OAT, including methadone, buprenorphine/naloxone ... (Source: SafetyLit)
Source: SafetyLit - September 18, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Pharmacy-related buprenorphine access barriers: an audit of pharmacies in counties with a high opioid overdose burden - Kazerouni NJ, Irwin AN, Levander XA, Geddes J, Johnston K, Gostanian CJ, Mayfield BS, Montgomery BT, Graalum DC, Hartung DM.
The objective of this study was to quantify the frequency of barriers encountered by patients seeking to fill buprenorphine... (Source: SafetyLit)
Source: SafetyLit - May 4, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
One in five pharmacies blocks access to key medication to treat addiction
(Oregon Health& Science University) One out of five pharmacies refuse to dispense a key medication to treat addiction, according to an audit of hundreds of pharmacies nationwide. Researchers found found that independent pharmacies and those in southern U.S. states were significantly more likely to restrict access to buprenorphine, also known as Suboxone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2021 Category: International Medicine & Public Health Source Type: news
Cassipa (Buprenorphine and Naloxone Sublingual Film) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 29, 2021 Category: Drugs & Pharmacology Source Type: news
Hudson Woman Sentenced to 15 Months for Tampering with Consumer Products and Unlawfully Obtaining Controlled Substances
FDA OCI, Kristina Coleman, Hudson NH, sentence, tampering, opioid, pharmacy technician, Nashua, oxycodone, baclofen, suboxone, muscle relaxant, replacement, controlled substance, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 2, 2021 Category: Medical Law Authors: DOJ Source Type: news
